港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

药捷安康-B

51.850

-1.900-3.53%

成交量：17.55万

成交额：891.10万

市值：205.79亿

市盈率：-66.02

高：53.800

开：52.750

低：48.660

收：53.750

52周最高：58.050

52周最低：20.200

股本：3.97亿

香港流通股本：3.02亿

量比：2.38

换手率：0.06%

股息：- -

股息率：- -

每股收益(LYR):-0.785

净资产收益率：-41.98%

总资产收益率：-24.05%

市净率：35.91

市盈率(LYR):-66.02

市销率: - -

数据加载中...

总览公司新闻公告

异动解读 | 药捷安康-B盘中大跌5.02%，疑似受中期业绩影响

药捷安康-B(02617)获纳入恒生指数系列成份股

药捷安康-B(02617.HK)发布中期业绩股东应占亏损1.23亿元同比收窄23.39%

药捷安康－Ｂ(02617)股价下跌5.023%，现价港币$52.0

阿斯达克财经

药捷安康-B(02617)获纳入恒生综合指数有望成为港股通标的

药捷安康-B涨超10%股价创新高，该股上市以来累涨260%

老虎资讯综合

药捷安康-B08月06日主力净流入47.2万元散户资金抛售

创新药东风浩荡：科创板未盈利IPO重新开闸

药捷安康-B07月30日主力净流出73.5万元散户资金买入

港股异动 | 药捷安康-B涨近13%创上市新高，核心产品获FDA快速通道认证

港股异动 | 药捷安康-B(02617.HK)涨超13%创上市新高较招股价已涨近1.8倍核心产品获FDA快速通道认证

药捷安康－Ｂ(02617)股价上升5%，现价港币$33.6

阿斯达克财经

港股IPO上半年表现亮眼，融资额荣登全球第一！下半年IPO机会抢先看

老虎资讯综合

递表前估值达26亿元！德适生物有哪些看点？

药捷安康-B07月21日主力净流出186.3万元散户资金买入

港股医疗IPO热度不减，11家募资超181亿，39家排队，百利天恒“闯关”倒计时

3家上市 1家过会长江产业集团所投企业批量IPO

药捷安康-B(02617)股东将股票存入华泰香港存仓市值14.76亿港元

药捷安康-B07月09日主力净流入11.9万元散户资金抛售

“IPO盛宴”强势回归

艾美达医药咨询

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02617/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"药捷安康-B","latestPrice":51.85,"timestamp":1756179370962,"preClose":53.75,"halted":0,"volume":175500,"delay":0,"floatShares":301666673,"shares":396897633,"eps":-0.7852789654897735,"marketStatus":"交易中","change":-1.9,"latestTime":"08-26 11:36:23","open":52.75,"high":53.8,"low":48.66,"amount":8911000,"amplitude":0.095628,"askPrice":51.85,"askSize":500,"bidPrice":51.55,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-0.7852789654897735,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1756180800000},"marketStatusCode":2,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":53.75,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":2.384911,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":301666673,"roa":"-24.05%","roe":"-41.98%","lyrEps":-0.785368,"volumeRatio":2.384911,"shares":396897633,"dividePrice":0,"high":53.8,"amplitude":0.095628,"preClose":53.75,"low":48.66,"week52Low":20.2,"pbRate":"35.91","week52High":58.05,"institutionHeld":0,"latestPrice":51.85,"eps":-0.7853678532772097,"divideRate":0,"volume":175500,"delay":0,"ttmEps":-0.7853678532772097,"open":52.75,"prevYearClose":13.15,"prevWeekClose":54.75,"prevMonthClose":37.95,"prevQuarterClose":30.15,"fiveDayClose":51.7,"twentyDayClose":40.9,"sixtyDayClose":13.15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2025-08-25","current":-71.114754,"percent":0.066667,"low":-72.789898,"twenty":-63.292817,"median":-44.380409,"eighty":-39.630155,"high":-17.403134,"avg":-49.174295,"sd":13.084245,"marketCap":21333247773},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-27","current":-36.622688,"twenty":-34.709071,"median":-32.493198,"eighty":-31.066553,"marketCap":11013909315},{"date":"2025-07-04","current":-44.802949,"twenty":-38.622694,"median":-35.660049,"eighty":-31.776499,"marketCap":13474674640},{"date":"2025-07-11","current":-39.630155,"twenty":-40.38446,"median":-38.336544,"eighty":-32.816725,"marketCap":11906928990},{"date":"2025-07-18","current":-43.957869,"twenty":-42.111612,"median":-39.630155,"eighty":-34.373739,"marketCap":13196846297},{"date":"2025-07-25","current":-49.067594,"twenty":-42.195906,"median":-40.285196,"eighty":-36.230637,"marketCap":14784436829},{"date":"2025-08-01","current":-50.963195,"twenty":-45.655878,"median":-41.371359,"eighty":-36.620356,"marketCap":15260713988},{"date":"2025-08-08","current":-58.015216,"twenty":-51.234741,"median":-42.017389,"eighty":-37.993773,"marketCap":17415868136},{"date":"2025-08-15","current":-66.867935,"twenty":-57.065221,"median":-42.261724,"eighty":-38.707864,"marketCap":20043330466},{"date":"2025-08-22","current":-72.723484,"twenty":-59.09189,"median":-43.957869,"eighty":-39.464263,"marketCap":21730145406},{"date":"2025-08-25","current":-71.114754,"twenty":-63.292817,"median":-44.380409,"eighty":-39.630155,"marketCap":21333247773}],"updateTime":1756179316999},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02617\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1100059125","title":"异动解读 | 药捷安康-B盘中大跌5.02%，疑似受中期业绩影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1100059125","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100059125?lang=zh_cn&edition=fundamental","pubTime":"2025-08-26 10:14","pubTimestamp":1756174471,"startTime":"0","endTime":"0","summary":"港股药捷安康-B今日盘中大跌5.02%，引发市场关注。此次股价下跌可能与公司近期发布的中期业绩报告有关。根据公司公告，药捷安康-B发布了截至2025年6月止的六个月中期业绩。报告显示，公司亏损收窄至1.23亿元人民币，相比去年同期的1.6亿元有所改善。这一消息本应对公司股价产生积极影响，但似乎未能抵消中期业绩带来的负面影响。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02617"],"gpt_icon":0},{"id":"2562228505","title":"药捷安康-B(02617)获纳入恒生指数系列成份股","url":"https://stock-news.laohu8.com/highlight/detail?id=2562228505","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562228505?lang=zh_cn&edition=fundamental","pubTime":"2025-08-25 22:34","pubTimestamp":1756132485,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药捷安康-B(02617)发布公告，根据恒生指数有限公司于2025年8月22日公布的恒生指数系列季度检讨结果，公司已获选并将纳入包括但不限于下述恒生指数系列成份股，自2025年9月8日起生效：1.恒生综合指数;2.恒生综合行业指数-医疗保健业;3.恒生综合中小型股指数;4.恒生综合小型股指数;5.恒生医疗保健指数;6.恒生创新药指数;7.恒生港股通创新药指数;8.恒生港股通创新药精选指数;及9.恒生港股通药品及生物技术(可投资)指数。公告称，公司获纳入恒生综合指数及上述指数反映投资者的认可度上升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1334891.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02833","02617","MCHmain","159271","BK1161","HHImain","HSI","513600","HSImain","MHImain"],"gpt_icon":0},{"id":"2562416612","title":"药捷安康-B(02617.HK)发布中期业绩 股东应占亏损1.23亿元 同比收窄23.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562416612","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562416612?lang=zh_cn&edition=fundamental","pubTime":"2025-08-25 20:22","pubTimestamp":1756124552,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","CNHmain","MUCmain","UCmain","MCNHmain","02617","CYB"],"gpt_icon":0},{"id":"2562213588","title":"药捷安康－Ｂ(02617)股价下跌5.023%，现价港币$52.0","url":"https://stock-news.laohu8.com/highlight/detail?id=2562213588","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562213588?lang=zh_cn&edition=fundamental","pubTime":"2025-08-25 14:05","pubTimestamp":1756101900,"startTime":"0","endTime":"0","summary":"[下跌股]药捷安康－Ｂ(02617) 股价在下午02:05比前收市价下跌5.023%，现股价为港币$52.0。至目前为止，今日最高价为$56.5，而最低价为$52.0。总成交量为15.45万股，总成交金额为港币$849.348万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2508252781/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2561647472","title":"药捷安康-B(02617)获纳入恒生综合指数 有望成为港股通标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2561647472","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561647472?lang=zh_cn&edition=fundamental","pubTime":"2025-08-22 20:40","pubTimestamp":1755866401,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，8月22日，恒生指数公司宣布截至2025年6月30日之恒生指数系列季度检讨结果，其中药捷安康-B获纳入恒生综合指数，变动将于9月5日(星期五)收市后实施并于9月8日(星期一)起生效，届时沪深交易所会相应调整港股通可投资标的范围。据华泰证券研报，药捷安康-B有可能被调入港股通，因其满足了包括市值、流动性和上市时间等在内的一系列标准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1333835.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","YANG","HSTECH","BK4614","HSCEI","HSCI","02617"],"gpt_icon":0},{"id":"1155093209","title":"药捷安康-B涨超10%股价创新高，该股上市以来累涨260%","url":"https://stock-news.laohu8.com/highlight/detail?id=1155093209","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155093209?lang=zh_cn&edition=fundamental","pubTime":"2025-08-12 11:35","pubTimestamp":1754969742,"startTime":"0","endTime":"0","summary":"8月12日，次新股$药捷安康-B(02617)$涨超10%股价创新高，该股上市以来累涨260%。","market":"hk","thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f9f5c19ed45485656d348326b21ae75c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2557371574","title":"药捷安康-B08月06日主力净流入47.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2557371574","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557371574?lang=zh_cn&edition=fundamental","pubTime":"2025-08-06 16:15","pubTimestamp":1754468139,"startTime":"0","endTime":"0","summary":"08月06日, 药捷安康-B股价涨0.46%，报收43.64元，成交金额630.4万元，换手率0.05%，振幅6.45%，量比1.03。药捷安康-B今日主力资金净流入47.2万元，上一交易日主力净流出0万元。该股近5个交易日上涨10.48%，主力资金累计净流入47.2万元；近20日主力资金累计净流出35.0万元，其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806170351a4785b29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806170351a4785b29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2556287969","title":"创新药东风浩荡：科创板未盈利IPO重新开闸","url":"https://stock-news.laohu8.com/highlight/detail?id=2556287969","media":"药智网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556287969?lang=zh_cn&edition=fundamental","pubTime":"2025-08-04 09:12","pubTimestamp":1754269930,"startTime":"0","endTime":"0","summary":"科创板未盈利IPO再度开闸，港股市场生物医药企业IPO热度前所未有，企业信心逐步恢复。01科创板未盈利IPO再开闸2019年，上海证券交易所新设科创板，并试点注册制，设置了五套上市标准。过去两年，科创板第五套IPO窗口关闭，超30家生物医药企业撤回科创板IPO申请。直到6月18日的陆家嘴论坛上，中国证监会主席吴清明确表示：将在创业板正式启用第三套标准，支持优质未盈利创新企业上市，并重启未盈利企业适用于科创板第五套标准上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804093952a4733e61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804093952a4733e61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01877","09606","688331","02617","01276","BK1574","688180","06978","09995"],"gpt_icon":0},{"id":"2555145046","title":"药捷安康-B07月30日主力净流出73.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2555145046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555145046?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 16:15","pubTimestamp":1753863345,"startTime":"0","endTime":"0","summary":"07月30日, 药捷安康-B股价跌3.42%，报收39.50元，成交金额780.4万元，换手率0.07%，振幅5.87%，量比0.46。药捷安康-B今日主力资金净流出73.5万元，上一交易日主力净流出0万元。该股近5个交易日上涨25.16%，主力资金累计净流入104.1万元；近20日主力资金累计净流出190.5万元，其中净流出天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730165842a46b41b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730165842a46b41b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2554515597","title":"港股异动 | 药捷安康-B涨近13%创上市新高，核心产品获FDA快速通道认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2554515597","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554515597?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 15:33","pubTimestamp":1753428796,"startTime":"0","endTime":"0","summary":"7月25日，$药捷安康-B$午后涨近13%，创上市新高。消息面上，药捷安康本月初宣布，其自主研发的多靶点激酶抑制剂替恩戈替尼，已获$美国食品$药物管理局授予治疗转移性去势抵抗性前列腺癌的快速通道认证。它也是全球首个可能同时抑制FGFR/JAK通路并针对转移性去势抵抗性前列腺癌具有临床疗效证据的研究药物。","market":"fut","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"011459e051e308f667dc3b10defbb054","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321925.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"港股异动 | 药捷安康-B涨近13创上市新高，核心产品获FDA快速通道认证","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2554375155","title":"港股异动 | 药捷安康-B(02617.HK)涨超13%创上市新高 较招股价已涨近1.8倍 核心产品获FDA快速通道认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2554375155","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554375155?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 15:08","pubTimestamp":1753427324,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"011459e051e308f667dc3b10defbb054","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2554568759","title":"药捷安康－Ｂ(02617)股价上升5%，现价港币$33.6","url":"https://stock-news.laohu8.com/highlight/detail?id=2554568759","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554568759?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 14:15","pubTimestamp":1753424100,"startTime":"0","endTime":"0","summary":"[上升股]药捷安康－Ｂ(02617) 股价在下午02:15比前收市价上升5%，现股价为港币$33.6。至目前为止，今日最高价为$33.6，而最低价为$31.65。总成交量为23.15万股，总成交金额为港币$759.991万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2507252293/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"1117162350","title":"港股IPO上半年表现亮眼，融资额荣登全球第一！下半年IPO机会抢先看","url":"https://stock-news.laohu8.com/highlight/detail?id=1117162350","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117162350?lang=zh_cn&edition=fundamental","pubTime":"2025-07-23 11:36","pubTimestamp":1753241761,"startTime":"0","endTime":"0","summary":"2025上半年港股市场势头向好，港股IPO上半年表现尤为亮眼，42宗首次公开招股发行，合共集资额逾过1,070亿港元，与去年同期相比，上市数量增长40%，融资总额飙升逾7倍。整体来看，2025年上半年港股市场凭借政策红利、资金回流与情绪修复实现强势复苏，医药、消费、A+H板块成为IPO主力；展望下半年，在巨头排队、政策持续利好的背景下，港股市场热度有望进一步延续。","market":"hk","thumbnail":"https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"港股IPO上半年表现亮眼，融资额荣登全球第一！下半年IPO机会抢先看","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06603","02643","02597","06168","03288","03880","09678","01828","09881","02605","02508","02648","02590","06883","02050","02573","02609","01304","02619","06613","02651","02592","02617"],"gpt_icon":0},{"id":"2553427502","title":"递表前估值达26亿元！德适生物有哪些看点？","url":"https://stock-news.laohu8.com/highlight/detail?id=2553427502","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553427502?lang=zh_cn&edition=fundamental","pubTime":"2025-07-21 16:41","pubTimestamp":1753087277,"startTime":"0","endTime":"0","summary":"自研医学影像基座模型，IPO前估值达26亿元德适生物成立于2016年，总部位于浙江杭州，是全球医学影像AI技术的引领者。虽然历经多轮融资，但截至2025年6月27日，德适生物的创始人、控股股东宋宁博士仍持有公司52.06%的表决权。德适生物还有一些地方值得留意。对比现金营运成本及年度亏损来看，德适生物的现金流相当吃紧。因此，此次能否在港股成功IPO对现在的德适生物来说具有重要影响。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1753084187133833687","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["09606","06681","BK1161","02617","BK1189"],"gpt_icon":0},{"id":"2553794294","title":"药捷安康-B07月21日主力净流出186.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2553794294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553794294?lang=zh_cn&edition=fundamental","pubTime":"2025-07-21 16:15","pubTimestamp":1753085745,"startTime":"0","endTime":"0","summary":"07月21日, 药捷安康-B股价跌4.36%，报收31.80元，成交金额1115.9万元，换手率0.12%，振幅9.77%，量比1.59。药捷安康-B今日主力资金净流出186.3万元，上一交易日主力净流出0万元。该股近5个交易日上涨8.16%，主力资金累计净流出186.3万元；近20日主力资金累计净流入455.0万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721165704a6b78af4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721165704a6b78af4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2551116742","title":"港股医疗IPO热度不减，11家募资超181亿，39家排队，百利天恒“闯关”倒计时","url":"https://stock-news.laohu8.com/highlight/detail?id=2551116742","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551116742?lang=zh_cn&edition=fundamental","pubTime":"2025-07-15 08:25","pubTimestamp":1752539117,"startTime":"0","endTime":"0","summary":"据LiveReport大数据，截至2025年7月14日，港股今年共计50家IPO，其中医疗保健行业合计11家，占比22%，今年的医疗保健行业的IPO数量接近去年全年的12家。","market":"other","thumbnail":"https://images.finet.hk/photoLib/title/202507_1/5bb97970-aeb9-4394-8077-488ef8d961bc.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202507_1/5bb97970-aeb9-4394-8077-488ef8d961bc.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/68759fed2308298517b7f12d","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["BK1161","01276","02592","BK1191","02617"],"gpt_icon":1},{"id":"2551065419","title":"3家上市 1家过会 长江产业集团所投企业批量IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2551065419","media":"荆楚网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551065419?lang=zh_cn&edition=fundamental","pubTime":"2025-07-14 16:22","pubTimestamp":1752481320,"startTime":"0","endTime":"0","summary":"湖北日报讯 7月14日从长江产业集团获悉，6月份至今， 长江产业集团参股基金所投企业批量IPO，已有3家上市、1家成功过会，主要为生物医药、半导体等硬科技企业。长江产业集团相关负责人表示，近期批量IPO的企业，不仅为集团带来资本增值，更以行业地位与技术创新力证明其投资决策的前瞻性与精准度。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714162732a449610c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714162732a449610c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["561980","02617","688729"],"gpt_icon":0},{"id":"2550589677","title":"药捷安康-B(02617)股东将股票存入华泰香港 存仓市值14.76亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550589677","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550589677?lang=zh_cn&edition=fundamental","pubTime":"2025-07-11 08:12","pubTimestamp":1752192779,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，7月10日，药捷安康-B(02617)股东将股票存入华泰香港，存仓市值14.76亿港元，占比15.86%。药捷安康宣布，其自主研发的多靶点激酶抑制剂替恩戈替尼(TT-00420)，已获美国食品药物管理局(FDA)授予治疗转移性去势抵抗性前列腺癌的快速通道认证。公司表示，替恩戈替尼目前处于全球三期注册实验的多靶点激酶抑制剂，靶向FGFR/VEGFR、JAK和Aurora激酶发挥抗肿瘤作用，目前正在美国与中国进行的临床试验显示，其在多种实体瘤治疗中具有疗效潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1316535.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2550680177","title":"药捷安康-B07月09日主力净流入11.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2550680177","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550680177?lang=zh_cn&edition=fundamental","pubTime":"2025-07-09 16:15","pubTimestamp":1752048956,"startTime":"0","endTime":"0","summary":"07月09日, 药捷安康-B股价涨1.15%，报收30.85元，成交金额1391.2万元，换手率0.15%，振幅10.16%，量比0.73。药捷安康-B今日主力资金净流入11.9万元，上一交易日主力净流出87.4万元。该股近5个交易日上涨11.17%，主力资金累计净流出108.2万元；近20日主力资金累计净流入641.3万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709170532a43ff84b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709170532a43ff84b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2550683564","title":"“IPO盛宴”强势回归","url":"https://stock-news.laohu8.com/highlight/detail?id=2550683564","media":"艾美达医药咨询","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550683564?lang=zh_cn&edition=fundamental","pubTime":"2025-07-09 15:00","pubTimestamp":1752044427,"startTime":"0","endTime":"0","summary":"2025年7月1日，上交所官网显示，武汉禾元生物科技股份有限公司科创板IPO成功通过上交所上市审核委员会审议，成为科创板第五套上市标准重启后首家过会的IPO企业。2025年的A股生物医药IPO市场呈现出积极且结构化的新格局。亦诺微医药、微脉、百力司康等数十家医健企业已向港交所递交上市申请，排队等候上市，场面火爆，预示着下半年IPO热潮将持续。此外，多个IPO项目获得投资者热烈追捧。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709150735a69ec54e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709150735a69ec54e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01801","LU1064131003.USD","LU1997245177.USD","BK0012","600276","159982","BK0239","LU1655091616.SGD","BK0196","BK0028","02561","01877","LU1064130708.USD","LU0405327148.USD","LU2488822045.USD","02617","LU1997244956.HKD","LU2148510915.USD","BK0183","LU1969619763.USD","LU0405327494.USD","LU2495084118.USD","LU1997245094.SGD","BK0060","02592","LU2328871848.SGD","LU1328615791.USD","BK0188"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":63,"code":"91000000","status":"200"}]}}